For safe, appropriate and effective clinical transfusion practice, following an evidence-based, multidisciplinary approach utilising the principles of patient blood management (PBM) is essential.
Use of blood components
Blood components are products containing cells or plasma derived from living human blood. Each blood component has specific clinical indications, benefits and potential risks.
Some types of anaemia, thrombocytopenia and platelet function disorders, bleeding disorders and massive transfusion are common clinical indications for blood components.
The transfusion process for the safe administration of blood products has a number of important steps that need to be followed from the decision to transfuse and informed consent right through to documentation and traceability.